ENG(エンドグリン前駆体)の世界市場:販売動向2018

【英語タイトル】Global ENG(Endoglin precursor) Sales Market Report 2018

QYResearchが出版した調査資料(QYR80705383)・商品コード:QYR80705383
・発行会社(調査会社):QYResearch
・発行日:2018年9月
・ページ数:123
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、世界主要国(日本、アメリカ、中国、ヨーロッパ等)
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥1,184,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ENG(エンドグリン前駆体)の世界市場について調査・分析し、ENG(エンドグリン前駆体)のメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、ENG(エンドグリン前駆体)産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・ENG(エンドグリン前駆体)市場概要
・ENG(エンドグリン前駆体)のメーカー別販売量・メーカー別シェア
・ENG(エンドグリン前駆体)の世界市場:種類別販売量
・ENG(エンドグリン前駆体)の世界市場:用途別販売量
・ENG(エンドグリン前駆体)の世界市場:地域別販売量・市場シェア
・ENG(エンドグリン前駆体)の米国市場規模
・ENG(エンドグリン前駆体)の中国市場規模
・ENG(エンドグリン前駆体)の欧州市場規模
・ENG(エンドグリン前駆体)の日本市場規模
・ENG(エンドグリン前駆体)の東南アジア市場規模
・ENG(エンドグリン前駆体)のインド市場規模
・ENG(エンドグリン前駆体)のメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・ENG(エンドグリン前駆体)のコスト分析・価格動向
・ENG(エンドグリン前駆体)の産業チェーン(サプライチェーン分析)
・ENG(エンドグリン前駆体)のマーケティング戦略・販売チャネル、流通業者
・ENG(エンドグリン前駆体)市場への影響要因分析
・ENG(エンドグリン前駆体)の世界市場予測
・ENG(エンドグリン前駆体)の米国市場予測
・ENG(エンドグリン前駆体)の中国市場予測
・ENG(エンドグリン前駆体)の欧州市場予測
・ENG(エンドグリン前駆体)の日本市場予測
・ENG(エンドグリン前駆体)の東南アジア市場予測
・ENG(エンドグリン前駆体)のインド市場予測
・ENG(エンドグリン前駆体)の種類別世界市場予測
・ENG(エンドグリン前駆体)の用途別世界市場予測
...
【レポートの概要】

In this report, the global ENG(Endoglin precursor) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split global into several key Regions, with sales (MT), revenue (Million USD), market share and growth rate of ENG(Endoglin precursor) for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global ENG(Endoglin precursor) market competition by top manufacturers/players, with ENG(Endoglin precursor) sales volume, Price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including
Aviva Systems Biology Corporation(USA)
Atlas Antibodies(Sweden)
Abbexa Ltd(UK)
Abiocode(US)
Boster Biological Technology(USA)
Biobyt(UK)
Bio-Rad(US)
Bioss Antibodies(US)
Biosensis(US)
BioLegend(US)
BioVision(US)
BethylLaboratories(US)
Epigentek(US)
EnzoLifeSciences(Switzerland)
Genetex(US)
Lifespan Biosciences(US)
Novus Biologicals(US)
Proteintech(US)
ProSci(US)
ProteoGenix(France)
R&D Systems(US)
Rockland(US)
St John’s Laboratory Ltd(UK)
Stemcell(Canada)
Thermo Fisher Scientific(US)
USBiological(US)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Above 90%
Above 95%
Above 99%
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Biopharmaceutical Companies
Hospitals
Bioscience Research Institutions
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global ENG(Endoglin precursor) Sales Market Report 2017
1 ENG(Endoglin precursor) Market Overview
1.1 Product Overview and Scope of ENG(Endoglin precursor)
1.2 Classification of ENG(Endoglin precursor) by Product Category
1.2.1 Global ENG(Endoglin precursor) Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global ENG(Endoglin precursor) Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Above 90%
1.2.4 Above 95%
1.2.5 Above 99%
1.2.6 Others
1.3 Global ENG(Endoglin precursor) Market by Application/End Users
1.3.1 Global ENG(Endoglin precursor) Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Biopharmaceutical Companies
1.3.3 Hospitals
1.3.4 Bioscience Research Institutions
1.3.5 Others
1.4 Global ENG(Endoglin precursor) Market by Region
1.4.1 Global ENG(Endoglin precursor) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.4.3 China ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.4.4 Europe ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.4.5 Japan ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.4.6 Southeast Asia ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.4.7 India ENG(Endoglin precursor) Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of ENG(Endoglin precursor) (2012-2022)
1.5.1 Global ENG(Endoglin precursor) Sales and Growth Rate (2012-2022)
1.5.2 Global ENG(Endoglin precursor) Revenue and Growth Rate (2012-2022)

2 Global ENG(Endoglin precursor) Competition by Players/Suppliers, Type and Application
2.1 Global ENG(Endoglin precursor) Market Competition by Players/Suppliers
2.1.1 Global ENG(Endoglin precursor) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global ENG(Endoglin precursor) Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global ENG(Endoglin precursor) (Volume and Value) by Type
2.2.1 Global ENG(Endoglin precursor) Sales and Market Share by Type (2012-2017)
2.2.2 Global ENG(Endoglin precursor) Revenue and Market Share by Type (2012-2017)
2.3 Global ENG(Endoglin precursor) (Volume and Value) by Region
2.3.1 Global ENG(Endoglin precursor) Sales and Market Share by Region (2012-2017)
2.3.2 Global ENG(Endoglin precursor) Revenue and Market Share by Region (2012-2017)
2.4 Global ENG(Endoglin precursor) (Volume) by Application

3 United States ENG(Endoglin precursor) (Volume, Value and Sales Price)
3.1 United States ENG(Endoglin precursor) Sales and Value (2012-2017)
3.1.1 United States ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
3.1.2 United States ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
3.1.3 United States ENG(Endoglin precursor) Sales Price Trend (2012-2017)
3.2 United States ENG(Endoglin precursor) Sales Volume and Market Share by Players
3.3 United States ENG(Endoglin precursor) Sales Volume and Market Share by Type
3.4 United States ENG(Endoglin precursor) Sales Volume and Market Share by Application

4 China ENG(Endoglin precursor) (Volume, Value and Sales Price)
4.1 China ENG(Endoglin precursor) Sales and Value (2012-2017)
4.1.1 China ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
4.1.2 China ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
4.1.3 China ENG(Endoglin precursor) Sales Price Trend (2012-2017)
4.2 China ENG(Endoglin precursor) Sales Volume and Market Share by Players
4.3 China ENG(Endoglin precursor) Sales Volume and Market Share by Type
4.4 China ENG(Endoglin precursor) Sales Volume and Market Share by Application

5 Europe ENG(Endoglin precursor) (Volume, Value and Sales Price)
5.1 Europe ENG(Endoglin precursor) Sales and Value (2012-2017)
5.1.1 Europe ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
5.1.2 Europe ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
5.1.3 Europe ENG(Endoglin precursor) Sales Price Trend (2012-2017)
5.2 Europe ENG(Endoglin precursor) Sales Volume and Market Share by Players
5.3 Europe ENG(Endoglin precursor) Sales Volume and Market Share by Type
5.4 Europe ENG(Endoglin precursor) Sales Volume and Market Share by Application

6 Japan ENG(Endoglin precursor) (Volume, Value and Sales Price)
6.1 Japan ENG(Endoglin precursor) Sales and Value (2012-2017)
6.1.1 Japan ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
6.1.2 Japan ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
6.1.3 Japan ENG(Endoglin precursor) Sales Price Trend (2012-2017)
6.2 Japan ENG(Endoglin precursor) Sales Volume and Market Share by Players
6.3 Japan ENG(Endoglin precursor) Sales Volume and Market Share by Type
6.4 Japan ENG(Endoglin precursor) Sales Volume and Market Share by Application

7 Southeast Asia ENG(Endoglin precursor) (Volume, Value and Sales Price)
7.1 Southeast Asia ENG(Endoglin precursor) Sales and Value (2012-2017)
7.1.1 Southeast Asia ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia ENG(Endoglin precursor) Sales Price Trend (2012-2017)
7.2 Southeast Asia ENG(Endoglin precursor) Sales Volume and Market Share by Players
7.3 Southeast Asia ENG(Endoglin precursor) Sales Volume and Market Share by Type
7.4 Southeast Asia ENG(Endoglin precursor) Sales Volume and Market Share by Application

8 India ENG(Endoglin precursor) (Volume, Value and Sales Price)
8.1 India ENG(Endoglin precursor) Sales and Value (2012-2017)
8.1.1 India ENG(Endoglin precursor) Sales and Growth Rate (2012-2017)
8.1.2 India ENG(Endoglin precursor) Revenue and Growth Rate (2012-2017)
8.1.3 India ENG(Endoglin precursor) Sales Price Trend (2012-2017)
8.2 India ENG(Endoglin precursor) Sales Volume and Market Share by Players
8.3 India ENG(Endoglin precursor) Sales Volume and Market Share by Type
8.4 India ENG(Endoglin precursor) Sales Volume and Market Share by Application

9 Global ENG(Endoglin precursor) Players/Suppliers Profiles and Sales Data
9.1 Aviva Systems Biology Corporation(USA)
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Atlas Antibodies(Sweden)
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Abbexa Ltd(UK)
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Abbexa Ltd(UK) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Abiocode(US)
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Abiocode(US) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Boster Biological Technology(USA)
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Boster Biological Technology(USA) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Biobyt(UK)
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Biobyt(UK) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Bio-Rad(US)
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Bio-Rad(US) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Bioss Antibodies(US)
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Bioss Antibodies(US) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Biosensis(US)
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Biosensis(US) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 BioLegend(US)
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 ENG(Endoglin precursor) Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 BioLegend(US) ENG(Endoglin precursor) Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 BioVision(US)
9.12 BethylLaboratories(US)
9.13 Epigentek(US)
9.14 EnzoLifeSciences(Switzerland)
9.15 Genetex(US)
9.16 Lifespan Biosciences(US)
9.17 Novus Biologicals(US)
9.18 Proteintech(US)
9.19 ProSci(US)
9.20 ProteoGenix(France)
9.21 R&D Systems(US)
9.22 Rockland(US)
9.23 St John’s Laboratory Ltd(UK)
9.24 Stemcell(Canada)
9.25 Thermo Fisher Scientific(US)
9.26 USBiological(US)

10 ENG(Endoglin precursor) Maufacturing Cost Analysis
10.1 ENG(Endoglin precursor) Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of ENG(Endoglin precursor)
10.3 Manufacturing Process Analysis of ENG(Endoglin precursor)

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 ENG(Endoglin precursor) Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of ENG(Endoglin precursor) Major Manufacturers in 2016
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global ENG(Endoglin precursor) Market Forecast (2017-2022)
14.1 Global ENG(Endoglin precursor) Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global ENG(Endoglin precursor) Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global ENG(Endoglin precursor) Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global ENG(Endoglin precursor) Price and Trend Forecast (2017-2022)
14.2 Global ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global ENG(Endoglin precursor) Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global ENG(Endoglin precursor) Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India ENG(Endoglin precursor) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global ENG(Endoglin precursor) Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global ENG(Endoglin precursor) Sales Forecast by Type (2017-2022)
14.3.2 Global ENG(Endoglin precursor) Revenue Forecast by Type (2017-2022)
14.3.3 Global ENG(Endoglin precursor) Price Forecast by Type (2017-2022)
14.4 Global ENG(Endoglin precursor) Sales Volume Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of ENG(Endoglin precursor)
Figure Global ENG(Endoglin precursor) Sales Volume Comparison (MT) by Type (2012-2022)
Figure Global ENG(Endoglin precursor) Sales Volume Market Share by Type (Product Category) in 2016
Figure Above 90% Product Picture
Figure Above 95% Product Picture
Figure Above 99% Product Picture
Figure Others Product Picture
Figure Global ENG(Endoglin precursor) Sales Comparison (MT) by Application (2012-2022)
Figure Global Sales Market Share of ENG(Endoglin precursor) by Application in 2016
Figure Biopharmaceutical Companies Examples
Table Key Downstream Customer in Biopharmaceutical Companies
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Bioscience Research Institutions Examples
Table Key Downstream Customer in Bioscience Research Institutions
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global ENG(Endoglin precursor) Market Size (Million USD) by Regions (2012-2022)
Figure United States ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure India ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate (2012-2022)
Figure Global ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players ENG(Endoglin precursor) Sales Volume (MT) (2012-2017)
Table Global ENG(Endoglin precursor) Sales (MT) of Key Players/Suppliers (2012-2017)
Table Global ENG(Endoglin precursor) Sales Share by Players/Suppliers (2012-2017)
Figure 2016 ENG(Endoglin precursor) Sales Share by Players/Suppliers
Figure 2017 ENG(Endoglin precursor) Sales Share by Players/Suppliers
Figure Global ENG(Endoglin precursor) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global ENG(Endoglin precursor) Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global ENG(Endoglin precursor) Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global ENG(Endoglin precursor) Revenue Share by Players
Table 2017 Global ENG(Endoglin precursor) Revenue Share by Players
Table Global ENG(Endoglin precursor) Sales (MT) and Market Share by Type (2012-2017)
Table Global ENG(Endoglin precursor) Sales Share (MT) by Type (2012-2017)
Figure Sales Market Share of ENG(Endoglin precursor) by Type (2012-2017)
Figure Global ENG(Endoglin precursor) Sales Growth Rate by Type (2012-2017)
Table Global ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global ENG(Endoglin precursor) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of ENG(Endoglin precursor) by Type (2012-2017)
Figure Global ENG(Endoglin precursor) Revenue Growth Rate by Type (2012-2017)
Table Global ENG(Endoglin precursor) Sales Volume (MT) and Market Share by Region (2012-2017)
Table Global ENG(Endoglin precursor) Sales Share by Region (2012-2017)
Figure Sales Market Share of ENG(Endoglin precursor) by Region (2012-2017)
Figure Global ENG(Endoglin precursor) Sales Growth Rate by Region in 2016
Table Global ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global ENG(Endoglin precursor) Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of ENG(Endoglin precursor) by Region (2012-2017)
Figure Global ENG(Endoglin precursor) Revenue Growth Rate by Region in 2016
Table Global ENG(Endoglin precursor) Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global ENG(Endoglin precursor) Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of ENG(Endoglin precursor) by Region (2012-2017)
Figure Global ENG(Endoglin precursor) Revenue Market Share by Region in 2016
Table Global ENG(Endoglin precursor) Sales Volume (MT) and Market Share by Application (2012-2017)
Table Global ENG(Endoglin precursor) Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of ENG(Endoglin precursor) by Application (2012-2017)
Figure Global ENG(Endoglin precursor) Sales Market Share by Application (2012-2017)
Figure United States ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure United States ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table United States ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table United States ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure United States ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table United States ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table United States ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure United States ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table United States ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table United States ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure United States ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Figure China ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure China ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure China ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table China ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table China ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure China ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table China ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table China ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure China ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table China ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table China ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure China ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Figure Europe ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure Europe ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table Europe ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table Europe ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure Europe ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table Europe ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table Europe ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure Europe ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table Europe ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table Europe ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure Europe ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Figure Japan ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure Japan ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table Japan ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table Japan ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure Japan ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table Japan ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table Japan ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure Japan ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table Japan ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table Japan ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure Japan ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Figure Southeast Asia ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure Southeast Asia ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table Southeast Asia ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table Southeast Asia ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table Southeast Asia ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Figure India ENG(Endoglin precursor) Sales (MT) and Growth Rate (2012-2017)
Figure India ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate (2012-2017)
Figure India ENG(Endoglin precursor) Sales Price (USD/Kg) Trend (2012-2017)
Table India ENG(Endoglin precursor) Sales Volume (MT) by Players (2012-2017)
Table India ENG(Endoglin precursor) Sales Volume Market Share by Players (2012-2017)
Figure India ENG(Endoglin precursor) Sales Volume Market Share by Players in 2016
Table India ENG(Endoglin precursor) Sales Volume (MT) by Type (2012-2017)
Table India ENG(Endoglin precursor) Sales Volume Market Share by Type (2012-2017)
Figure India ENG(Endoglin precursor) Sales Volume Market Share by Type in 2016
Table India ENG(Endoglin precursor) Sales Volume (MT) by Application (2012-2017)
Table India ENG(Endoglin precursor) Sales Volume Market Share by Application (2012-2017)
Figure India ENG(Endoglin precursor) Sales Volume Market Share by Application in 2016
Table Aviva Systems Biology Corporation(USA) Basic Information List
Table Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Aviva Systems Biology Corporation(USA) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Atlas Antibodies(Sweden) Basic Information List
Table Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Atlas Antibodies(Sweden) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Abbexa Ltd(UK) Basic Information List
Table Abbexa Ltd(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Abbexa Ltd(UK) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Abiocode(US) Basic Information List
Table Abiocode(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abiocode(US) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Abiocode(US) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Abiocode(US) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Boster Biological Technology(USA) Basic Information List
Table Boster Biological Technology(USA) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Boster Biological Technology(USA) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Biobyt(UK) Basic Information List
Table Biobyt(UK) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biobyt(UK) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Biobyt(UK) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Biobyt(UK) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Bio-Rad(US) Basic Information List
Table Bio-Rad(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bio-Rad(US) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Bio-Rad(US) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Bio-Rad(US) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Bioss Antibodies(US) Basic Information List
Table Bioss Antibodies(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Bioss Antibodies(US) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table Biosensis(US) Basic Information List
Table Biosensis(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Biosensis(US) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure Biosensis(US) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure Biosensis(US) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table BioLegend(US) Basic Information List
Table BioLegend(US) ENG(Endoglin precursor) Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure BioLegend(US) ENG(Endoglin precursor) Sales Growth Rate (2012-2017)
Figure BioLegend(US) ENG(Endoglin precursor) Sales Global Market Share (2012-2017
Figure BioLegend(US) ENG(Endoglin precursor) Revenue Global Market Share (2012-2017)
Table BioVision(US) Basic Information List
Table BethylLaboratories(US) Basic Information List
Table Epigentek(US) Basic Information List
Table EnzoLifeSciences(Switzerland) Basic Information List
Table Genetex(US) Basic Information List
Table Lifespan Biosciences(US) Basic Information List
Table Novus Biologicals(US) Basic Information List
Table Proteintech(US) Basic Information List
Table ProSci(US) Basic Information List
Table ProteoGenix(France) Basic Information List
Table R&D Systems(US) Basic Information List
Table Rockland(US) Basic Information List
Table St John's Laboratory Ltd(UK) Basic Information List
Table Stemcell(Canada) Basic Information List
Table Thermo Fisher Scientific(US) Basic Information List
Table USBiological(US) Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of ENG(Endoglin precursor)
Figure Manufacturing Process Analysis of ENG(Endoglin precursor)
Figure ENG(Endoglin precursor) Industrial Chain Analysis
Table Raw Materials Sources of ENG(Endoglin precursor) Major Players in 2016
Table Major Buyers of ENG(Endoglin precursor)
Table Distributors/Traders List
Figure Global ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Global ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global ENG(Endoglin precursor) Price (USD/Kg) and Trend Forecast (2017-2022)
Table Global ENG(Endoglin precursor) Sales Volume (MT) Forecast by Regions (2017-2022)
Figure Global ENG(Endoglin precursor) Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global ENG(Endoglin precursor) Sales Volume Market Share Forecast by Regions in 2022
Table Global ENG(Endoglin precursor) Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global ENG(Endoglin precursor) Revenue Market Share Forecast by Regions (2017-2022)
Figure Global ENG(Endoglin precursor) Revenue Market Share Forecast by Regions in 2022
Figure United States ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure China ENG(Endoglin precursor) Revenue and Growth Rate Forecast (2017-2022)
Figure Europe ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Europe ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Japan ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India ENG(Endoglin precursor) Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure India ENG(Endoglin precursor) Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global ENG(Endoglin precursor) Sales (MT) Forecast by Type (2017-2022)
Figure Global ENG(Endoglin precursor) Sales Volume Market Share Forecast by Type (2017-2022)
Table Global ENG(Endoglin precursor) Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global ENG(Endoglin precursor) Revenue Market Share Forecast by Type (2017-2022)
Table Global ENG(Endoglin precursor) Price (USD/Kg) Forecast by Type (2017-2022)
Table Global ENG(Endoglin precursor) Sales (MT) Forecast by Application (2017-2022)
Figure Global ENG(Endoglin precursor) Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


★調査レポート[ENG(エンドグリン前駆体)の世界市場:販売動向2018] (コード:QYR80705383)販売に関する免責事項を必ずご確認ください。
★調査レポート[ENG(エンドグリン前駆体)の世界市場:販売動向2018]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆